ALC

#428
Alcon Inc. Ordinary Shares
66.6 5 USD
+1.05%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
66.29
66.76
Year Range
61.84
92.55
Daily Change
+1.05%
Monthly Change
-9.21%
6 month change
-15.92%
Year Change
-23.65%
Previous Close
65.9 6
Open
66.2 9
Low
66.2 9
High
66.7 6
Volume
1 068
Open full chart Full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
  • Market Capitalization 32.49 B
  • Employee 26 K
  • Founded N/A
  • CEO David J. Endicott
  • Website www.alcon.com
  • Headquarter Switzerland
  • FIGI UNKNOWN
  • Industry Medical Instruments & Supplies
Total revenue
Net income
Total debt
Free cash flow
Cash & equivalents

Alcon Inc. Ordinary Shares

Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people. Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies.

News